AIDS Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS
New HIV/AIDS study findings reported from Centers for Disease Control and Prevention
November 3rd, 2008
"We assessed the effect of daily cotrimoxazole, essential for HIV care, on development of antifolate-resistant Plasmodium falciparum. naso-pharyngeal Streptococcus pneumoniae (pneumococcus), and commensal Escherichia coli. HIV-positive subjects with CD4 cell count < 350 cells/mu L (lower-CD4; N = 692) received cotrimoxazole; HIV-positive with CD4 cell count >= 350 cells/mu L (higher-CD4; N = 336) and HIV-negative subjects (N = 132) received multivitamins," investigators in the United States report. "Specimens were collected at baseline, 2 weeks, monthly, and at sick visits during 6 months of follow-up to compare changes in resistance, with higher-CD4 as referent....
Source: AIDS Weekly (2008-11-03)
|
